Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr;42(4):275-294.
doi: 10.1007/s40266-025-01189-2. Epub 2025 Mar 11.

Medicine Optimisation and Deprescribing Intervention Outcomes for Older People with Dementia or Mild Cognitive Impairment: A Systematic Review

Nicola Andrews  1   2 , Cindy Brooks  1   2 , Michele Board  3 , Simon Fraser  2   4 , Sue Latter  1 , Kirsty Aplin  5 , Beth McCausland  5   6 , Eloise Radcliffe  2   4 , Jay Amin  5   6 , Rosemary Lim  7 , Ellen van Leeuwen  8   9 , Kinda Ibrahim  10   11
Affiliations

Medicine Optimisation and Deprescribing Intervention Outcomes for Older People with Dementia or Mild Cognitive Impairment: A Systematic Review

Nicola Andrews et al. Drugs Aging. 2025 Apr.

Abstract

Background: Polypharmacy is common amongst older people with dementia or mild cognitive impairment (MCI), increasing the risk of medication-related harm. Medicine optimisation and deprescribing to reduce polypharmacy is considered feasible, safe and can lead to improved health. However, for those living with dementia or MCI, this can be challenging. This systematic review aimed to summarise the evidence on the outcomes of medicine optimisation and deprescribing interventions for older people with dementia or MCI.

Methods: Literature was searched using CINAHL, Embase, Medline, PsychINFO, Web of Science and the Cochrane Library from database inception to January 2024. Papers reporting data specific to people with dementia or MCI from medicine optimisation and deprescribing interventional research studies of any design and in any setting were included. A narrative synthesis was conducted owing to heterogeneity of study designs and outcomes. Quality was assessed using the Mixed Methods Appraisal Tool.

Results: A total of 32 papers reporting on 28 studies were included, with samples ranging from 29 to 17,933 patients and a mean patient age ranging from 74 to 88 years. Of the studies, 60% were undertaken in long-term care settings. Involvement of patients and/or carers in interventions was limited. Papers were grouped as either incorporating a medication review component (n = 13), education component (n = 5) or both (n = 14). Studies primarily focussed on medication-related outcomes, generally showing a positive effect on decreasing the number and improving appropriateness of medications. Fewer papers reported clinical outcomes (behavioural and psychological symptoms of dementia, falls, quality of life and cognition) with mixed findings. A reduction or no change in mortality or hospital attendance demonstrated safety of the interventions in the few papers reporting these outcomes. The quality of the evidence was mixed.

Conclusions: Medicine optimisation and deprescribing interventions generally reduced the number and increased the appropriateness of medications, and although less frequently reported, these interventions seemed to be safe and showed an absence of worsening of clinical outcomes. This review highlights a need for further research, particularly in people with dementia or MCI living at home, with more focus on clinical outcomes and a greater involvement of patients and informal carers.

Protocol registration: The protocol was published in the International Prospective Register of Systematic Reviews (PROSPERO) [Ref: CRD42023398139].

PubMed Disclaimer

Conflict of interest statement

Declarations. Funding: This study was funded by the National Institute for Health and Care Research Applied Research Collaboration Wessex. The views expressed in this publication are those of the authors and not necessarily those of the National Institute for Health and Care Research or the Department of Health and Social Care. Conflict of Interests: The authors have no competing interests to declare that are relevant to the content of this article. Availability of Data and Material: Data supporting the findings of this study are available within the paper and its Supplementary Information. Ethics Approval: Not applicable. Consent to Participate: Not applicable. Code Availability: Not applicable. Consent for Publication: Not applicable. Author Contributions: N.A., M.B., S.F., S.L., J.A., R.L. and K.I. contributed to the conception and design of the review. N.A., C.B., S.F., K.A., B.M., J.A., R.L., E.v.L. and K.I. completed literature search and screening. N.A., C.B., M.B., S.L., K.A., R.L. and K.I. extracted data from included papers. M.B. and E.R. assessed the quality of the papers. N.A. drafted the manuscript, and all the authors revised and edited the manuscript. All the authors read and approved the final manuscript.

Figures

Fig. 1:
Fig. 1:
PRISMA flowchart
See this image and copyright information in PMC

References

    1. Clague F, Mercer SW, McLean G, Reynish E, Guthrie B. Comorbidity and polypharmacy in people with dementia: insights from a large, population-based cross-sectional analysis of primary care data. Age Ageing. 2017;46:33–9. - PubMed
    1. Park HY, Park JW, Song HJ, Sohn HS, Kwon JW. The association between polypharmacy and dementia: a nested case-control study based on a 12-year longitudinal cohort database in South Korea. PLoS ONE. 2017. 10.1371/journal.pone.0169463. - PMC - PubMed
    1. Mueller C, Molokhia M, Perera G, Veronese N, Stubbs B, Shetty H, et al. Polypharmacy in people with dementia: associations with adverse health outcomes. Exp Gerontol. 2018;106:240–5. - PubMed
    1. Onder G, Liperoti R, Foebel A, Fialova D, Topinkova E, van der Roest HG, et al. Polypharmacy and mortality among nursing home residents with advanced cognitive impairment: results from the SHELTER study. J Am Med Dir Assoc. 2013. 10.1016/j.jamda.2013.03.014. - PubMed
    1. Ramsey CM, Gnjidic D, Agogo GO, Allore H, Moga D. Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis. Alzheimers Dement TRCI. 2018. 10.1016/j.trci.2017.10.008. - PMC - PubMed

Publication types